Total usage of carbapenems and piperacillin-tazobactam in paediatric acute care settings across the UK, year 2011–2012
| Carbapenems | Piperacillin-tazobactam | |||
|---|---|---|---|---|
| District general hospitals (349 children on antibiotics) | Tertiary referral hospitals (898 children on antibiotics) | District general hospitals (349 children on antibiotics) | Tertiary referral hospitals (898 children on antibiotics) | |
| Total DDD/100 inpatients | 36.4 | 56.0 | 39.7 | 20.0 |
| Total children, n (%)* | 7 (2.0) | 54 (6.0) | 14 (4) | 68 (7.6) |
| General paediatric, n children (%)† | 6 (85.7) | 14 (25.9) | 11 (78.6) | 9 (13.2) |
| PICU, n children (%) | 1 (14.3) | 17 (31.5) | 0 | 12 (17.6) |
| Paediatric surgery, n children (%) | 0 | 6 (11.1) | 3 (21.4) | 7 (10.3) |
| Haematology–oncology–transplant, n children (%) | 0 | 10 (18.5) | 0 | 19 (27.9) |
| Others, n children (%) | 0 | 7 (13.0) | 0 | 21 (30.9) |
| Underlying disease vs previously healthy children, n children (%)† | 3 (42.9) | 49 (90.7) | 12 (85.7) | 67 (98.5) |
*Per cent among the total number of children on antibiotics per type of hospitals.
†Per cent among the number of children on carbapenems or piperacillin-tazobactam.
DDD, defined daily doses; PICU, paediatric intensive care units.